Emet Surgical

Company Overview

Snapshot

Founded in February 2021 by Bob Witkow, Emet Surgical operates with 1-10 employees. The company has raised $1.3 million across three funding rounds from Bob Witkow. In May 2024, Emet Surgical secured a grant from Inspiranto Innovation Fund.

Business overview

Emet Surgical is dedicated to redefining minimally invasive surgery through its ESP (Enhanced Surgical Precision) system. This AI/ML-powered platform provides real-time surgical guidance and cancerous tissue recognition, supporting surgeons by delivering data-driven insights directly on the surgical video feed. The company aims to reduce complications and reoperations while improving incidental cancer detection, addressing challenges in the healthcare and medical devices sectors. Emet Surgical's technology is compatible with various robotic and laparoscopic systems, leveraging proprietary IP and licensed technology from the University of Minnesota.

Strategic signal

In May 2024, Emet Surgical secured a grant from Inspiranto Innovation Fund, signaling continued external validation and support for its innovative surgical precision technology. This funding is crucial for advancing the ESP system, which recently achieved a key milestone by identifying cancerous tissue in real-time during video analysis, moving the company closer to clinical trials and regulatory submissions planned for late 2025 and early 2026.

Company Intelligence Q&A

What is Emet Surgical's core technology?

Emet Surgical's core technology is the ESP (Enhanced Surgical Precision) system, an AI/ML-powered platform that provides real-time surgical guidance and cancerous tissue recognition during minimally invasive surgery.

When was Emet Surgical founded and by whom?

Emet Surgical was founded in February 2021 by cancer survivor and tech entrepreneur Bob Witkow.

What was a significant recent milestone for Emet Surgical?

In May 2024, Emet Surgical secured a grant from Inspiranto Innovation Fund. Additionally, in May 2024, the ESP system reached a milestone by identifying cancerous tissue in real time during video analysis, a key step toward clinical trials.

What is the total capital raised by Emet Surgical?

Emet Surgical has raised a total of $1.3 million across three funding rounds.

What is the primary goal of Emet Surgical's technology?

Emet Surgical aims to improve surgical outcomes by enhancing precision and decision-making during minimally invasive surgery, reducing complications and reoperations, and improving incidental cancer detection.